FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Guanidine Hydrochloride Tablets
Status: Discontinuation
»Therapeutic Categories: Neurology

Merck Sharp & Dohme Corp. (New 09/28/2020)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
125 mg tablets (NDC 0085-0492-01) 09/28/2020 To be discontinued on or near October 2020.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English